Tonix Pharmaceuticals Holding Corp. - FORM 10-K - EX-21.01 - SUBSIDIARIES OF THE COMPANY - March 15, 2021

Attached files

file	filename
EX-31.02 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Tonix Pharmaceuticals Holding Corp.	ex31-02.htm
10-K - ANNUAL REPORT - Tonix Pharmaceuticals Holding Corp.	tnxp-10k_123120.htm
EX-32.01 - CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - Tonix Pharmaceuticals Holding Corp.	ex32-01.htm
EX-31.01 - CRERTIFICATION OF CHIEF EXECUTIVE OFFICER - Tonix Pharmaceuticals Holding Corp.	ex31-01.htm
EX-23.01 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Tonix Pharmaceuticals Holding Corp.	ex23-1.htm
EX-10.28 - PURCHASE AND SALE AGREEMENT - Tonix Pharmaceuticals Holding Corp.	ex10-28.htm
EX-4.06 - DESCRIPTION OF REGISTRANTS SECURITIES - Tonix Pharmaceuticals Holding Corp.	ex4-06.htm

Tonix Pharmaceuticals, Inc. 10-K

Exhibit 21.01

SUBSIDIARIES OF THE COMPANY

Subsidiary Name		State/ Jurisdiction of Incorporation/Formation

Tonix Pharmaceuticals, Inc.		Delaware
Krele, LLC		Delaware
Tonix Pharmaceuticals (Canada), Inc.		New Brunswick, Canada
Tonix Pharma Holdings Limited		Ireland
Tonix Pharma Limited		Ireland
Jenner LLC		Delaware
Tonix Medicines, Inc.		Delaware